GENE ONLINE|News &
Opinion
Blog

.

Зеркало официального сайта всегда доступно для входа на Мостбет, даже при ограничениях. Скачать Mostbet – это шаг к удобству и азартным развлечениям.

Если вы ищете место для увлекательных ставок, обратите внимание на Joycasino, где лучшие предложения для игроков ждут вас.
2018-10-11| Asia-PacificPolicy

Live Report – 2018 BioJapan: Witness Japan’s biotechnology industry development policy and the innovation of pharmaceutical industry

by GeneOnline
Share To

2018 BioJapan was launched on October 10th at Pacifico Yokohama National Convention Hall. GeneOnline listed some of the highlights shared by two key opinion leaders in medicine.

Concentrate on the development of biotechnology in order to solve the issues on society.

Mazakazu Tokura, the president of SUMITOMO CHEMICAL , also a member of Council for Science, Technology and Innovation (CSTI), mentioned that Japanese government has outlined “Society 5.0” project in “Japan Revitalization Strategy”, in order to integrate the relevant units and implement the effective resource allocation and structural reform.

Mazakazu Tokura, the president of SUMITOMO CHEMICAL , also a member of Council for Science, Technology and Innovation (CSTI)
Mazakazu Tokura, the president of SUMITOMO CHEMICAL , also a member of Council for Science, Technology and Innovation (CSTI)

Regarding to this, Japanese government’s appeal is to let the policy and technology development become closer, more organized and flexible, and commit to expanding the market and accelerating the development of computer science and biotechnology.

The technology integration is real data and domain technology for biotechnology, which combines big data in various fields with cutting edge technologies such as genetic technology, AIoT, bioinformatics, etc. As well as connects to the country that has sound system on biomedical, such as the United States, United Kingdom, Germany, etc., in order to become the well-known country in global biotechnology industry.

The future of drug development and innovation

George Nakayama, president of Japan Pharmaceutical Manufacturers Association (JPMA), introduced that JPMA consists of 71 research-based pharmaceuticals in Japan and is a research-oriented voluntary organization.

George Nakayama, president of Japan Pharmaceutical Manufacturers Association (JPMA)
George Nakayama, president of Japan Pharmaceutical Manufacturers Association (JPMA)

He mentioned that Japan should work hard in three directions to catch up with the United States. To begin with, the establishment of the infrastructure, including the establishment of a health care database, such as genome and clinical diagnostic information, and the construction of ID facilities. Then, in order to provide sufficient funds for basic scientific research, the government and industry should cooperate to create profits. Finally, the government should establish an ecosystem without borders, especially establish a close relationship with the United States actively.

“Stay tuned to GeneOnline for more special articles on BioJapan 2018”

medtex最新-e1538653867506

 

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Silicon Valley in the Crosshairs as EU Readies to Strike U.S. Big Tech
2025-02-06
IPO
China’s Ascentage Snatches First Biotech IPO Price of 2025, Raking in $126M
2025-01-24
United Imaging Announces Major Expansion of U.S. Manufacturing Space
2025-01-09
LATEST
South Korea’s Olix Strikes $660M Deal with Eli Lilly for Phase 1 MASH candidate
2025-02-11
22 USA States Sue Trump Administration for Slashing Critical Medical Research Funding
2025-02-11
The Fallout of the USAID Funding Freeze: Implications for Global Health and Biopharmaceutical Innovation
2025-02-11
Trump’s Trade War Shake-Up: How U.S. Tariffs Could Disrupt Global Pharma
2025-02-10
Precision Medicine Market Skyrocketing, Shaking the Industry with $470.53 Billion Expected by 2034
2025-02-10
Super Bowl LIX and the Biotech Sector: A New Arena for Engagement
2025-02-09
What the PlayStation Network Outage Can Teach the Biotech Industry
2025-02-08
EVENT
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
Scroll to Top